Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Recruiting × Prednisone × Clear all

Phase

Phase 2 51 Phase 3 24 Phase 1/2 15 Phase 1 14 Phase EARLY_PHASE1 2 Phase 2/3 2 Phase 4 1

Status

Completed 11 Unknown 5 Not yet recruiting 2 Active not recruiting 2 Terminated 1 Suspended 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Myasthenia Gravis 1 Adrenal Insufficiency 1

Interventions

Propofol 8 Rituximab 7 Sevoflurane 6 Dexamethasone 6 Trastuzumab 5 Magnetic Resonance Spectroscopy 5 Enoxaparin 5 Carboplatin 5 Bevacizumab 5 Specimen Handling 4 Nivolumab 4 Indocyanine Green 4 Capecitabine 4 Bupivacaine 4 pembrolizumab 3 atezolizumab 3 apixaban 3 Lenalidomide 3 Gemcitabine 3 Docetaxel 3 Cyclophosphamide 3 zanubrutinib 2 venetoclax 2 trastuzumab deruxtecan 2 trametinib 2 tislelizumab 2 ribociclib 2 polyethylene glycol 3350 2 pirtobrutinib 2 pertuzumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07221838 2026-04-09

OCTAGON

Alexion Pharmaceuticals, Inc.

Phase 4 Recruiting

Adrenal Insufficiency, Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡